{
    "organizations": [],
    "uuid": "3fae2f0c58fb6002e277cc80c7d50d6eade269f1",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-drreddys-laboratories-updates-on-r/brief-dr-reddys-laboratories-updates-on-re-inspection-at-formulations-mfg-plant-in-bachupally-idUSFWN1PJ119",
    "ord_in_thread": 0,
    "title": "BRIEF-Dr.Reddy's Laboratories Updates on Re-inspection At Formulations Mfg Plant In Bachupally",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 24 (Reuters) - Dr.Reddy’s Laboratories Ltd:\n* THERE HAS BEEN RE-INSPECTION BY GERMAN REGULATOR AT CO‘S FORMULATIONS MANUFACTURING UNIT 2 PLANT IN BACHUPALLY, HYDERABAD‍​\n* BETAPHARM INFORMED THAT CURRENT STATUS OF EU GMP NON-COMPLIANCE IS TO BE WITHDRAWN FROM GOVERNMENT. OF UPPER BAVARIA Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-24T21:25:00.000+02:00",
    "crawled": "2018-01-25T12:58:29.024+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "laboratory",
        "ltd",
        "german",
        "regulator",
        "co",
        "formulation",
        "manufacturing",
        "unit",
        "plant",
        "bachupally",
        "betapharm",
        "informed",
        "current",
        "status",
        "eu",
        "gmp",
        "withdrawn",
        "government",
        "upper",
        "bavaria",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}